Company / Free Cash Flow
CHINA PHARMA HOLDINGS, INC. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$88.9K
FY2025
5-year range
-$909.6K / $88.9K
FY2021-FY2025
Trend
+112.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 10 years, ranging from -$909,567 in FY2021 to $4M in FY2016.
Based on SEC 10-K filings.
$88,937 in FY2025 with a 5-year CAGR of -28.4%.
Improved from -$711,203 to $88,937 over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -28.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -28.4%, indicating a declining trend.
- In FY2025, free cash flow increased 112.5% year-over-year.
- Peak free cash flow was recorded in FY2016.
- Lowest free cash flow in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $88.9K | +112.5% |
| FY2024 | -$711.2K | +0.0% |
| FY2023 | -$711.2K | +12.4% |
| FY2022 | -$811.5K | +10.8% |
| FY2021 | -$909.6K | -292.6% |
| FY2020 | $472.3K | -74.2% |
| FY2019 | $1.8M | +159.8% |
| FY2018 | $704.7K | -73.9% |
| FY2017 | $2.7M | -33.0% |
| FY2016 | $4.0M | +294.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026